News

Palantir's Q1 earnings failed to meet guidance expectations, driving selloff concerns. Find out if PLTR has more to rise or ...
Here are the latest analyst rating upgrades by Seeking Alpha analysts: Palantir (NASDAQ:PLTR). Sell to buy by Dhierin Bechai.
US stocks dropped as the Nasdaq 100 and Palantir tumbled, with traders eyeing Fed policy signals and unresolved global trade ...
Software firm, Palantir (NASDAQ: PLTR) is up more than 8.5% after reporting solid earnings growth on Monday. The company ...
Palantir reported a 71% increase in U.S. commercial revenue and a 45% gain in U.S. government revenue in the period, showing ...
The rise of artificial intelligence (AI) is expected to add $15.7 trillion to the worldwide economy by 2030. AI colossus ...
Palantir Technologies ( PLTR 1.44%) shares have advanced 550% since January 2024. For context, it was the best performing ...
Is there still value to be found in Estée Lauder? Plus, a look at how a digital bridging finance platform is reshaping the ...
Despite impressive revenue and operating income growth, Palantir shares dropped 12%. Read what warrants caution about PLTR ...
Smaller-scale trades involved Pacific Biosciences of California Inc (NASDAQ: PACB) and 10X Genomics Inc (NASDAQ: TXG ), with ARK purchasing 194,298 and 18,177 shares respectively, totaling $213,727 ...
Shares have advanced in Asia after the U.S. and China said they are planning trade talks in Switzerland later this week ...